PureTech Health PLC
09 July 2026
PDMR DEALING NOTIFICATION
|
1 |
Details of the person discharging managerial responsibilities/person closely associated |
||||||||||||||||
|
a) |
Name |
Robert Lyne Sharon Barber-Lui John LaMattina Michele Holcomb |
|||||||||||||||
|
2 |
Reason for the notification |
||||||||||||||||
|
a) |
Position/status |
Robert Lyne - Chief Executive Officer, Executive Director Sharon Barber-Lui - Interim Board Chair; Non-Executive Director John LaMattina - Non-Executive Director Michele Holcomb - Non-Executive Director |
|||||||||||||||
|
b) |
Initial notification/Amendment |
Initial notification |
|||||||||||||||
|
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
||||||||||||||||
|
a) |
Name |
PureTech Health plc |
|||||||||||||||
|
b) |
LEI |
213800LVPDNO2Z9T9I39 |
|||||||||||||||
|
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||||||||||||||||
|
a) |
Description of the financial instrument, type of instrument Identification code |
|
|||||||||||||||
|
b) |
Nature of the transaction |
Purchase of shares in market |
|||||||||||||||
|
c) |
Price(s) and volume(s) |
|
|||||||||||||||
|
d) |
Aggregated information
|
|
|||||||||||||||
|
e) |
Date of the transaction |
7-8 July 2026 |
|||||||||||||||
|
f) |
Place of the transaction |
London Stock Exchange (XLON) |
|||||||||||||||
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
ENDRNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.